Bigul

Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window

In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 11th February, 2021 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2020. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st January, 2021 till 48 hours of declaration of results i.e. 13th February, 2021 (both days inclusive).
02-02-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Holding Of Board Meeting On 11Th February, 2021 To Consider Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2020

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 11th February, 2021 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2020. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st January, 2021 till 48 hours of declaration of results i.e. 13th February, 2021 (both days inclusive).
02-02-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Submission Of Signed Minutes Of Annual General Meeting Held On 31.12.2020

Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2020.
19-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Submission Of Signed Minutes Of Annual General Meeting Held On 31.12.2020

Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2020.
19-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Submission Of Signed Minutes Of Annual General Meeting Held On 31.12.2020

Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2020.
19-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 31st December, 2020.
12-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Statement Of Investor Complaints For The Quarter Ended December 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Yogesh AgrawalDesignation :- Managing Director / Whole Time Director
12-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Shareholding for the Period Ended December 31, 2020

Genomic Valley Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
08-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Genomic Valley Biotech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-01-2021
Bigul

Genomic Valley Biotech Ltd - 539206 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby submitting the Voting Results alongwith the Scrutinizer Report issued by Scrutinizer appointed for conducting remote e-voting and voting at the venue of Annual General Meeting.
01-01-2021
Next Page
Close

Let's Open Free Demat Account